They may also have subclinical conditions that could be affected by metabolic changes
The STEP clinical trials, which tested semaglutide at multiple dose levels, showed that participants lost an average of 15% of their baseline body weight over 68 weekstranslating to roughly 0.25 to 0.75 pounds weekly on average, though results cluster around higher losses during active treatment phases
Many patients taking spironolactone for hypertension or hormonal concerns wonder whether they can safely add semaglutide to their treatment plan
However, the reality is far more nuanced, especially when medications like tirzepatide come into play
BelloBella tirzepatide expires after 30 days, which is standard for most compounded peptide formulations
Focus on balanced mealsthe goal is fueling at the right level, not continuing to reduce